| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2011 | US20110092493 Dose-controlled transdermal promethazine compositions and methods of use |
| 04/21/2011 | US20110092492 Imidazo compounds |
| 04/21/2011 | US20110092491 Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity |
| 04/21/2011 | US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents |
| 04/21/2011 | US20110092489 3-Aryl-Substituted Quinazolones, and Uses Thereof |
| 04/21/2011 | US20110092488 Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections |
| 04/21/2011 | US20110092487 Novel 3,8-diaza-bicyclo[3.2.1]octane-and 3,9-diaza-bicyclo[3.3.1]-nonane-3-carboxylic acid ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/21/2011 | US20110092486 Ih channel inhibitors for the promotion of wakefulness |
| 04/21/2011 | US20110092485 Substituted benzoazepines as toll-like receptor modulators |
| 04/21/2011 | US20110092484 Therapeutic or prophylactic agent for cerebral aneurysm |
| 04/21/2011 | US20110092483 Screening molecules with anti-prion activity: kits, methods and screened molecules |
| 04/21/2011 | US20110092482 Methods and compositions |
| 04/21/2011 | US20110092481 Quinoline or isoquinoline substituted p2x7 antagonists |
| 04/21/2011 | US20110092480 Substituted Heterocyclic Derivatives and Their Pharmaceutical Use and Compositions |
| 04/21/2011 | US20110092479 Pyrazole [3, 4-b] pyridine raf inhibitors |
| 04/21/2011 | US20110092478 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp |
| 04/21/2011 | US20110092477 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 04/21/2011 | US20110092476 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 04/21/2011 | US20110092475 2-substituted-ethynylthiazole derivatives and uses of same |
| 04/21/2011 | US20110092474 Diamino-pyridine, pyrimidine, and pyrazine modulators of the histamine H4 receptor |
| 04/21/2011 | US20110092473 Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties |
| 04/21/2011 | US20110092472 Enzymatic process for obtaining 17 alpha- monoesters of cortexolone and/or its 9,11- dehydroderivatives |
| 04/21/2011 | US20110092471 Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 04/21/2011 | US20110092470 Method of treating men with erectile dysfunction |
| 04/21/2011 | US20110092469 Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy |
| 04/21/2011 | US20110092468 Pharmaceutical Calcimimetics |
| 04/21/2011 | US20110092467 7-And 9-Carbamate, Urea, Thiourea, Thiocarbamate, And Heteroaryl-Amino Substituted Tetracycline Compounds |
| 04/21/2011 | US20110092465 Monomeric pyrophosphate complexes and methods of treatment using the complexes |
| 04/21/2011 | US20110092464 Neurogenesis by modulating angiotensin |
| 04/21/2011 | US20110092463 Combination for use in the treatment of inflammatory disorders |
| 04/21/2011 | US20110092462 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 04/21/2011 | US20110092461 Pyridyl inhibitors of hedgehog signalling |
| 04/21/2011 | US20110092460 Cyclopropyl polymerase inhibitors |
| 04/21/2011 | US20110092459 Alpha helix mimetics and methods relating thereto |
| 04/21/2011 | US20110092458 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases |
| 04/21/2011 | US20110092457 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 04/21/2011 | US20110092456 Methods of increasing cAMP levels and uses thereof |
| 04/21/2011 | US20110092454 Methods For Treating Mycoplasma Related Conditions In Livestock |
| 04/21/2011 | US20110092453 Treatments and prevention of hydrocephalus |
| 04/21/2011 | US20110092452 Compositions and methods for diagnosing and treating pancreatic cancer |
| 04/21/2011 | US20110092451 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 04/21/2011 | US20110092449 Treatment of fibrotic conditions |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092440 Method of regulating cell growth using a proteasome inhibitor |
| 04/21/2011 | US20110092423 INHIBITORS OF Akt ACTIVITY |
| 04/21/2011 | US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091586 Compositions containing amines and use thereof |
| 04/21/2011 | US20110091584 Lymphatic vessel stabilizer |
| 04/21/2011 | US20110091583 Antiallergic marine biopolymers |
| 04/21/2011 | US20110091580 Extract of rosmarinus officinalis l. leaves for pharmaceutical applications |
| 04/21/2011 | US20110091578 Method of stimulating tissue healing |
| 04/21/2011 | US20110091577 Drug release coatings on calcuim phosphate and uses thereof |
| 04/21/2011 | US20110091576 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growrh factors of stem cells |
| 04/21/2011 | US20110091574 Treatment of adenocarcinoma expressing lkb1 with mtor inhibitor in combination with cox2 inhibitor |
| 04/21/2011 | US20110091573 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 04/21/2011 | US20110091570 Compositions and Devices for Antisepsis and Anticoagulation |
| 04/21/2011 | US20110091566 Controlled release pharmaceutical compositions |
| 04/21/2011 | US20110091565 Method of forming non-immunogenic hydrophobic protein nanoparticles and uses therefor |
| 04/21/2011 | US20110091563 Orally-disintergrating solid preparation |
| 04/21/2011 | US20110091562 Nanogels for cellular delivery of therapeutics |
| 04/21/2011 | US20110091560 Compositions of nanoparticles and methods of making the same |
| 04/21/2011 | US20110091558 Pharmaceutical Compositions of Entacapone, Levodopa and Carbidopa with Improved Bioavailability |
| 04/21/2011 | US20110091556 Antimicrobial compositions and methods of use |
| 04/21/2011 | US20110091555 Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders. |
| 04/21/2011 | US20110091554 Injectable composite material suitable for use as a bone substitute |
| 04/21/2011 | US20110091552 Use of Bcl Inhibitors for the Treatment of Scarring Caused By Cutaneous Wounds, Burns and Abrasions |
| 04/21/2011 | US20110091551 Wound covering comprising octenidine dihydrochloride for use in the antisepsis of catheter insertion points |
| 04/21/2011 | US20110091549 Modulating Drug Release Rate By Controlling The Kinetics Of The pH Transition In Hydrogels |
| 04/21/2011 | US20110091547 Pharmaceutical Compositions Comprising Brivaracetam |
| 04/21/2011 | US20110091544 Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| 04/21/2011 | US20110091542 Baclofen and r-baclofen gastroretentive drug delivery systems |
| 04/21/2011 | US20110091541 Preparation of formulations of angiotensin II at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 04/21/2011 | US20110091540 Polymeric compositions and their method of use in combination with active agents |
| 04/21/2011 | US20110091539 Micronized Tanaproget and Compositions Containing Same |
| 04/21/2011 | US20110091538 Polymer adapted to release bioactive agents in vivo, pharmaceutical composition and method of preparation thereof |
| 04/21/2011 | US20110091537 Anti-misuse solid oral pharmaceutical form provided with a specific modified release profile |
| 04/21/2011 | US20110091535 Solid pharmaceutical formulation |
| 04/21/2011 | US20110091534 Compositions comprising polymeric micelles for drug delivery |
| 04/21/2011 | US20110091532 Composition for the treatment of arthritis containing a dibenzo-p-dioxin derivative as the active ingredient |
| 04/21/2011 | US20110091531 Cooling Composition |
| 04/21/2011 | US20110091525 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 04/21/2011 | US20110091523 Cochleate compositions directed against expression of proteins |
| 04/21/2011 | US20110091520 Sustained Release Intraocular Implants and Methods for Treating Ocular Neuropathies |
| 04/21/2011 | US20110091515 Drug-eluting medical devices |
| 04/21/2011 | US20110091511 Transdermal delivery of drugs based on crystal size |
| 04/21/2011 | US20110091510 Nanorod materials and methods of making and using same |
| 04/21/2011 | US20110091509 Benzonatate compositions and methods of use |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091506 Vaccine compositions |
| 04/21/2011 | US20110091505 Treatment of Mammalian Physiological Reaction of IgE Antibodies Present in Said Mammal Upon Contact With the Corresponding Antigen |
| 04/21/2011 | US20110091501 Recombinant Rhinovirus Vectors |
| 04/21/2011 | US20110091488 Water-swellable polymers |
| 04/21/2011 | US20110091486 Inhibition of post-radiation tumor growth |
| 04/21/2011 | US20110091485 Modulation of cell junctions |
| 04/21/2011 | US20110091482 Expression of kir in human cancer cells as a biomarker for immuno-escape and cancer metastasis |
| 04/21/2011 | US20110091474 Compositions and Methods For Diagnosing and Treating Diabetic Micro Vascular Complications |
| 04/21/2011 | US20110091469 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 04/21/2011 | US20110091467 Compositions and methods for modulating dopamine neurotransmission |
| 04/21/2011 | US20110091459 Imidazole modulators of muscarinic acetylcholine receptor m3 |